1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Peru Pharmaceuticals and Healthcare Report Q3 2016

Peru Pharmaceuticals and Healthcare Report Q3 2016

  • July 2016
  • -
  • Business Monitor International
  • -
  • 86 pages

Includes 3 FREE quarterly updates

BMI View: The presidential election result will maintain the attractiveness of Peru's pharmaceutical andhealthcare sector. A Fujimori administration will further bolster Peru's business environment andencourage increasing investment in Peru's pharmaceutical manufacturing sector. Government commitmentto healthcare will continue to improve domestic pharmaceutical consumption.

Headline Expenditure Projections

- Pharmaceuticals: PEN4.98bn (USD1.56bn) in 2015 to PEN5.32bn (USD1.61bn) in 2016; +6.8% inlocal currency terms and 3.0% in US dollar terms. Forecast unchanged from previous quarter.

- Healthcare: PEN34.9bn (USD11.0bn) in 2015 to PEN38.5bn (USD11.7bn) in 2016; +10.0% in localcurrency terms and 6.2% in US dollar terms. Forecast revised upwards from previous quarter.

Table Of Contents

Peru Pharmaceuticals and Healthcare Report Q3 2016
BMI Industry View 7
Table: Headline Pharmaceuticals and Healthcare Forecasts (Peru 2014-2020) 7
SWOT 9
Industry Forecast 11
Pharmaceutical Market Forecast 11
Table: Pharmaceutical Sales, Historical Data And Forecasts (Peru 2012-2020) 13
Healthcare Market Forecast 14
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Peru 2012-2020) 16
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Peru 2012-2020) 16
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Peru 2012-2020) 16
Prescription Drug Market Forecast 17
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Peru 2012-2020) 18
Patented Drug Market Forecast 19
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Peru 2012-2020) 20
Generic Drug Market Forecast 21
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Peru 2012-2020) 24
OTC Medicine Market Forecast 25
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Peru 2012-2020) 26
Pharmaceutical Trade Forecast 27
Table: Pharmaceutical Trade Data And Forecasts (Peru 2014-2020) 28
Table: Pharmaceutical Trade Data And Forecasts local currency (Peru 2014-2020) 29
Industry Risk Reward Indices 30
Americas Risk/Reward Index 30
Peru Risk/Reward Index 35
Rewards 35
Risks 36
Regulatory Review 38
Intellectual Property Issues 40
Pricing Regime 42
Table: Peruvian Watchdog of Pharmaceutical Products (Observatorio Peruano de Productos Farmaceuticos, OPPF) 43
Reimbursement Regime 43
Table: Price Components Of Two Imported Medicines In Both Private And Public Sectors 44
Market Overview 46
Healthcare Sector 47
Table: MINSA's Decentralised Institutions and Institutes, 2015 47
Table: Healthcare Resources (Peru 2010-2015) 49
Table: Healthcare Personnel (Peru 2010-2015) 50
Table: Healthcare Activity (Peru 2010-2015) 50
Research and Development 51
Clinical Trials 52
Epidemiology 53
Competitive Landscape 57
Research-Based Industry 57
Table: Multinational Market Activity 59
Table: Members of ADIFAN, 2014 60
Generic Drugmakers 60
Pharmaceutical Distribution 61
Pharmaceutical Retail Sector 62
Company Profile 65
Hersil 65
Novartis 68
Sanofi 70
Unimed 73
Demographic Forecast 75
Demographic Outlook 75
Table: Population Headline Indicators (Peru 1990-2025) 76
Table: Key Population Ratios (Peru 1990-2025) 76
Table: Urban/Rural Population and Life Expectancy (Peru 1990-2025) 77
Table: Population By Age Group (Peru 1990-2025) 77
Table: Population By Age Group % (Peru 1990-2025) 78
Glossary 80
Methodology 82
Pharmaceutical Expenditure Forecast Model 82
Healthcare Expenditure Forecast Model 82
Notes On Methodology 83
Risk/Reward Index Methodology 84
Index Overview 85
Table: Pharmaceutical Risk/Reward Index Indicators 85
Indicator Weightings 86

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

  • $ 10995
  • Industry report
  • September 2016
  • by Global Data

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024 Summary Attention deficit hyperactivity disorder (ADHD) is characterized by excessive levels ...

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

  • $ 6995
  • Industry report
  • November 2016
  • by GBI Research

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation Summary Asthma is a chronic condition affecting ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.